Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

CSLLY Relative to the S&P 500

CSLLY Relative to the Sector

Seasonal Chart Analysis

Analysis of the CSL Limited (OTCMKT:CSLLY) seasonal charts above shows that a Buy Date of January 16 and a Sell Date of May 6 has resulted in a geometric average return of 3.79% above the benchmark rate of the S&P 500 Total Return Index over the past 17 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 17 years by an average of 6.41% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.

To download CSLLY seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: CSLLY